The proposed suit covers GeneDx shareholders from April 16, 2025 to May 4, 2026 and centers on allegations that the Fabric Genomics acquisition was misrepresented before a $31.2 million impairment and guidance cut.
verifying reliability
No specialized terms available for this topic.